NewCelX Ltd. (Nasdaq: NCEL) is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company’s integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. NewCelX is headquartered in Zurich, Switzerland, with research and development operations in Ness Ziona, Israel.
| Website | http://www.newcelx.com |
| Employees | 29 (13 on RocketReach) |
| Founded | 2009 |
| Address | The Circle, Kloten, Zurich 8302, CH |
| Industry | Biotechnology Research |
Looking for a particular NewCelX employee's phone or email?
NewCelX Questions
Alex Zwyer is the Chief Business Officer and Executive Director of NewCelX.
13 people are employed at NewCelX.
NewCelX is based in Kloten, Zurich.
Top NewCelX Employees
-
23
-
Eric Konofal
Director Translational Neurosciences at NewCelX
Île-de-France, France5+1 -
Ronen Twito
Executive Chairman and CEO at NewCelX
Tel Aviv District, Israel1 -
Lior Schori
Researcher at NewCelX
Tel Aviv-Yafo, IL -
Itzik Toledo
Associate Researcher at NewCelX
Tel Aviv-Yafo, IL1
